Thursday, July 11, 2024 2:00:57 PM
Question is, what will that potential translate into pricewise upon MHRA approval. I've seen estimates ranging from a modest increase to some suggesting $5 or 6 and more. If there isn't a strong move, will momentum fail and the price retreat back?
I don't hold it, but Thermo has an interest in OTLK, so I check in on it from time to time. Biotech with a treatment for retinal disease. Price collapsed following a regulator rejection a few years ago, but the company persevered and finally got a FHMA approval July 8th, just days ago. The reaction has been muted, only about a 70-cent move on a 7-dollar stock. Now I know you can't really compare OTLK to NWBO, but the large short position in the latter will fight to keep the price down and AF and his ilk will likely be involved in some shenanigans to hold the price down. I keep my expectations low - would be happy if the share price got into the dollar range and held it, two dollars would be great for now.
I don't hold it, but Thermo has an interest in OTLK, so I check in on it from time to time. Biotech with a treatment for retinal disease. Price collapsed following a regulator rejection a few years ago, but the company persevered and finally got a FHMA approval July 8th, just days ago. The reaction has been muted, only about a 70-cent move on a 7-dollar stock. Now I know you can't really compare OTLK to NWBO, but the large short position in the latter will fight to keep the price down and AF and his ilk will likely be involved in some shenanigans to hold the price down. I keep my expectations low - would be happy if the share price got into the dollar range and held it, two dollars would be great for now.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
